ARQT
NASDAQ
$27.53
Arcutis Biotherapeutics Inc (ARQT)
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $34.62 (+25.75%)
Market Cap
$3.47B
Free Cash Flow Yield
0.77%
Beta (5Y)
1.24
Price Chart
Valuation
Market Cap$3.47B
Forward P/E158.73
P/S8.36
P/B17.68
Profitability
Total Revenue (TTM)$414M
Gross Profit (TTM)$378M
EBITDA$6.01M
Profit Margin-10.7%
Operating Margin-8.6%
EPS-$0.02
Financial Health
Debt-to-Equity57.7%
Free Cash Flow Yield0.77%
Growth & Risk
EPS 5Y CAGR-58.89%
Beta (5Y)1.24
Sharpe Ratio1.22